Tenders Are Invited For Antineoplastic And Immunomodulating Agents – Framework Agreement For Oncological Drugs 16 Lots

Antineoplastic And Immunomodulating Agents – Framework Agreement For Oncological Drugs 16 Lots. Cetuximabum Sol. Perf. 5Mg/Ml - 20 Ml,Pertuzumabum Conc.Pt.Sol./Perf. 420Mg/14 Ml,Cabazitaxelum Conc. + Solv. /Alone. Perf. 60 Mg (1.5Ml Concentrate + 4.5Ml Solvent),Docetaxelum Conc. Pt. Sol. / Perf. 20Mg/Ml - 7Ml,Paclitaxelum Conc. Pt. Sol. Perf. 6Mg/Ml - 25 Ml,Docetaxelum Conc. Pt. Sol. / Perf. 20Mg/Ml - 4Ml,Doxorubicinum Pulb. + Mix. Pt. Conc. Pt. Available Liposome. Pt. Perf. (Flac.Lipoz.+Flac.Sol.Buffer) 50Mg/Flac.,Trastuzumabum Pulb. Pt. Conc. Pt. Sol. Perf. 150 Mg,Epirubicinum Sol. Inj / Perf. 2Mg/Ml - 25 Ml,Oxaliplatinum Liof. Pt. Sol. / Perf. 5Mg/Ml - 20 Ml / 100 Mg,Cisplatinum Conc. Pt. Sol. / Perf. 1 Mg/Ml -50 Ml,Carboplatinum Conc. Pt. Sol. / Perf. 10Mg/Ml - 15Ml,Fluorouracilum / Conc. Pt. Sol. Inj. / Perf. 50Mg/Ml-100 Ml,Gemcitabinum Pulb. Pt. Sol. Perf. 100Mg/Ml – 10 Ml (1000 Mg),Etoposidum Conc. Pt. Sol. / Perf. 20 Mg/Ml-10 Ml,Pemetrexed Pulb. Pt. Sol. Perf. 25Mg/Ml-20 Ml 500 Mg